FDA.reportPublic FDA data

scopolamine hydrobromide 0.01 MG

RxCUI
1046712
RxNorm name
scopolamine hydrobromide 0.01 MG
Term type
SCDC
Status
Active
Updated
2026-08-02 18:42:44

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122010
Active start
122010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.01 MG / 1 EACHscopolamine

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
scopolamine9601

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRscopolamine hydrobromide 0.01 MG1NAMES
RxNorm Namescopolamine hydrobromide 0.01 MG1NAMES
TTYSCDC1ATTRIBUTES
RxCUI10467121CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01FAAnticholinergicsATC1-4scopolamine
ATCA04ADOther antiemeticsATC1-4scopolamine
ATCN05CMOther hypnotics and sedativesATC1-4scopolamine
FDASPLN0000175574AnticholinergicEPChas_epcscopolamine
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moascopolamine
MEDRTD012601ScopolamineCHEMhas_ingredientscopolamine hydrobromide
MEDRTD012601ScopolamineCHEMhas_ingredientscopolamine
MEDRTD000647AmnesiaDISEASEinducesscopolamine
MEDRTD000647AmnesiaDISEASEinducesscopolamine hydrobromide
MEDRTD003108Colonic DiseasesDISEASEmay_treatscopolamine
MEDRTD003108Colonic DiseasesDISEASEmay_treatscopolamine hydrobromide
MEDRTD004238DiverticulitisDISEASEmay_treatscopolamine
MEDRTD004238DiverticulitisDISEASEmay_treatscopolamine hydrobromide
MEDRTD004342Drug HypersensitivityDISEASEci_withscopolamine
MEDRTD004342Drug HypersensitivityDISEASEci_withscopolamine hydrobromide
MEDRTD004403DysenteryDISEASEmay_treatscopolamine
MEDRTD004403DysenteryDISEASEmay_treatscopolamine hydrobromide
MEDRTD005158Facial ParalysisDISEASEmay_treatscopolamine
MEDRTD005158Facial ParalysisDISEASEmay_treatscopolamine hydrobromide
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withscopolamine hydrobromide
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withscopolamine
MEDRTD006470HemorrhageDISEASEci_withscopolamine hydrobromide
MEDRTD006470HemorrhageDISEASEci_withscopolamine
MEDRTD007415Intestinal ObstructionDISEASEci_withscopolamine hydrobromide
MEDRTD007415Intestinal ObstructionDISEASEci_withscopolamine
MEDRTD015863IridocyclitisDISEASEmay_treatscopolamine
MEDRTD015863IridocyclitisDISEASEmay_treatscopolamine hydrobromide
MEDRTD009041Motion SicknessDISEASEmay_preventscopolamine hydrobromide
MEDRTD009041Motion SicknessDISEASEmay_preventscopolamine
MEDRTD009157Myasthenia GravisDISEASEci_withscopolamine
MEDRTD009157Myasthenia GravisDISEASEci_withscopolamine hydrobromide
MEDRTD015878MydriasisDISEASEinducesscopolamine hydrobromide
MEDRTD015878MydriasisDISEASEinducesscopolamine
MEDRTD009325NauseaDISEASEmay_preventscopolamine
MEDRTD009325NauseaDISEASEmay_preventscopolamine hydrobromide
MEDRTD010301Parkinson Disease, PostencephaliticDISEASEmay_treatscopolamine
MEDRTD010301Parkinson Disease, PostencephaliticDISEASEmay_treatscopolamine hydrobromide
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatscopolamine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatscopolamine hydrobromide
MEDRTD013610TachycardiaDISEASEci_withscopolamine hydrobromide
MEDRTD013610TachycardiaDISEASEci_withscopolamine
MEDRTD013971ThyrotoxicosisDISEASEci_withscopolamine hydrobromide
MEDRTD013971ThyrotoxicosisDISEASEci_withscopolamine
MEDRTD014839VomitingDISEASEmay_preventscopolamine
MEDRTD014839VomitingDISEASEmay_preventscopolamine hydrobromide
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moascopolamine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moascopolamine hydrobromide
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moascopolamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moascopolamine hydrobromide
MEDRTN0000000130Serotonin AntagonistsMOAhas_moascopolamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moascopolamine hydrobromide
MEDRTN0000008635Decreased GI MotilityPEhas_pescopolamine
MEDRTN0000008635Decreased GI MotilityPEhas_pescopolamine hydrobromide
MEDRTN0000008657Decreased Histamine ActivityPEhas_pescopolamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pescopolamine hydrobromide
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pescopolamine hydrobromide
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pescopolamine
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_pescopolamine
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_pescopolamine hydrobromide
MEDRTN0000008893Decreased Serotonin ActivityPEhas_pescopolamine
MEDRTN0000008893Decreased Serotonin ActivityPEhas_pescopolamine hydrobromide
MEDRTN0000009808Positive ChronotropyPEhas_pescopolamine hydrobromide
MEDRTN0000009808Positive ChronotropyPEhas_pescopolamine
MEDRTN0000009820Pupillary DilationPEhas_pescopolamine hydrobromide
MEDRTN0000009820Pupillary DilationPEhas_pescopolamine
MEDRTN0000009842Salivation InhibitionPEhas_pescopolamine
MEDRTN0000009842Salivation InhibitionPEhas_pescopolamine hydrobromide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESIN_EXPRESSED_FLAGP
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH0.01 MG